Atlas Trials

The Clinical Efficacy and Influence Factors of Individualized Treatment of Ustekinumab in Crohn's Disease

Clinical trial NCT06785493 · COMPLETED

Trial details

NCT number
NCT06785493
Sponsor
Second Affiliated Hospital of Wenzhou Medical University
Status
COMPLETED
Study type
OBSERVATIONAL
IBD (Inflammatory Bowel Disease)
Start date
2020-07-01
Primary completion
2024-07-31
Enrollment
122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.